ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)
Nucleic Acid Therapeutics
container_j7oxm7fzlrdqpitsuratmvvwka
Mary Ann Liebert
Homepage URLs
http://www.liebertonline.com/loi/nat |
http://www.liebertpub.com/nat |
http://www.liebertpub.com/products/product.aspx?pid=397 |
Example Publications
Pharmacodynamic and Pharmacokinetic Properties of Full Phosphorothioate Small Interfering RNAs for Gene Silencing In Vivo
Christian Berk, Gianluca Civenni, Yuluan Wang, Christian Steuer, Carlo V. Catapano, Jonathan Hall
2020
|
Nucleic Acid Therapeutics
doi:10.1089/nat.2020.0852 pmcid:PMC8215415
Oligonucleotides and the COVID-19 Pandemic: A Perspective
John J. Rossi, Daniel Rossi
2020
|
Nucleic Acid Therapeutics
doi:10.1089/nat.2020.0868 pmcid:PMC7249453
Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to Epithelial Cell Adhesion Molecule-Positive Tumor Cells
Joanna Macdonald, Justin Henri, Adelaide Jamieson, Delphine Denoyer, Ingrid J.G. Burvenich, Normand Pouliot, Sarah Shigdar
2020
|
Nucleic Acid Therapeutics
doi:10.1089/nat.2019.0807 pmcid:PMC7133447
Systemic Evaluation of Chimeric LNA/2′OMe Steric Blockers for Myotonic Dystrophy Type 1 Therapy
Melina Christou, Jesper Wengel, Kleitos Sokratous, Kyriacos Kyriacou, Georgios Nikolaou, Leonidas A. Phylactou, Nikolaos P. Mastroyiannopoulos
2019
|
Nucleic Acid Therapeutics
doi:10.1089/nat.2019.0811 pmcid:PMC7133450
Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis
Jessica E. Sutherland, Julia L. Hettinger, Amy Chan, Jason Gilbert, Garvin L. Warner, Wendell P. Davis
2019
|
Nucleic Acid Therapeutics
doi:10.1089/nat.2019.0796 pmcid:PMC6987735